peroxynitrous acid has been researched along with microcystin in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (microcystin) | Trials (microcystin) | Recent Studies (post-2010) (microcystin) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 1,119 | 1 | 530 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albadrani, M; Bose, D; Brooks, B; Chatterjee, S; Diehl, AM; Jule, Y; Kimono, D; Mondal, A; Nagarkatti, M; Nagarkatti, P; Porter, DE; Raychoudhury, S; Sarkar, S; Scott, GI; Seth, RK | 1 |
1 other study(ies) available for peroxynitrous acid and microcystin
| Article | Year |
|---|---|
Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cytokines; Enzyme Inhibitors; Hepatic Stellate Cells; Kupffer Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcystins; MicroRNAs; NADPH Oxidase 2; NADPH Oxidases; Non-alcoholic Fatty Liver Disease; Peroxynitrous Acid; Protein Phosphatase 2 | 2019 |